InvestorsHub Logo
Followers 20
Posts 5350
Boards Moderated 0
Alias Born 01/04/2012

Re: Jeffqdh post# 5951

Thursday, 09/22/2016 7:33:25 PM

Thursday, September 22, 2016 7:33:25 PM

Post# of 14907
Jeff, their most recent Corporate Presentation puts the market at $77 Million for the Anti-infective. As Jadite stated in a previous conference call Przybyl stated that the combined EBITDA for Nilutamide and the anti-infective is projected to be at least $20 million.

Hopefully they also secured the EEMT contract they were working on.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News